Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Archrock (AROC) Asset Writedowns and Impairment (2016 - 2025)

Archrock (AROC) has disclosed Asset Writedowns and Impairment for 17 consecutive years, with $640000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment rose 40.66% to $640000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.2 million, a 111.64% increase, with the full-year FY2025 number at $1.2 million, up 111.64% from a year prior.
  • Asset Writedowns and Impairment was $640000.0 for Q4 2025 at Archrock, up from $56000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $836000.0 in Q3 2021 to a low of -$711000.0 in Q4 2021.
  • A 5-year average of $188200.0 and a median of $207500.0 in 2023 define the central range for Asset Writedowns and Impairment.
  • Peak YoY movement for Asset Writedowns and Impairment: soared 1878.72% in 2021, then plummeted 235.66% in 2024.
  • Archrock's Asset Writedowns and Impairment stood at -$711000.0 in 2021, then surged by 184.39% to $600000.0 in 2022, then grew by 22.33% to $734000.0 in 2023, then tumbled by 38.01% to $455000.0 in 2024, then skyrocketed by 40.66% to $640000.0 in 2025.
  • Per Business Quant, the three most recent readings for AROC's Asset Writedowns and Impairment are $640000.0 (Q4 2025), $56000.0 (Q3 2025), and $312000.0 (Q2 2025).